In an interview with CNBC-TV18, Bhaskar Narayana, Finance Director & CFO, Natco Pharma gave his perspective on the tie-up with Alvogen and the first-to-file opportunity for Tamiflu.
first published: Feb 9, 2011 04:15 pm
A collection of the most-viewed Moneycontrol videos.
Live: Positive start to November series, Nifty sustains above 26,000 | Closing Bell
Live: Will Nifty continue to chase 26,000? | Opening Bell
Stock Market LIVE: Sensex, Nifty Off Day’s Lows | F&O Expiry Sparks Volatility | Closing Bell
‘Ashoka University Won’t Expand to Other Cities’ | Pramath Raj Sinha & Ashish Dhawan LIVE
